Anti-neuroinflammatory agents for the treatment of Alzheimer’s disease

By Zhou Wei   Hu Wenhui  

Future Medicinal Chemistry, Vol. 5, Iss. 13, 2013-09 ,pp. : 1559-1571

Future Science

Access to resources Recommend Favorite

Monoclonal antibodies against ββ-amyloid (Aββ) for the treatment of Alzheimer's disease: the Aββ target at a crossroads

By Panza Francesco   Frisardi Vincenza   Imbimbo Bruno P   Seripa Davide   Solfrizzi Vincenzo   Pilotto Alberto  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer's disease

By Tundis Rosa   Menichini Federica   Conforti Filomena   Loizzo Monica R.   Bonesi Marco   Statti Giancarlo   Menichini Francesco  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 3, 2009-06 ,pp. : 818-824

Informa Healthcare

Access to resources Recommend Favorite

Top-leads from natural products for treatment of Alzheimer's disease: docking and molecular dynamics study

By Ngo Son Tung   Li Mai Suan  

Molecular Simulation, Vol. 39, Iss. 4, 2013-04 ,pp. : 279-291

Taylor & Francis Ltd

Access to resources Recommend Favorite

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

By Akuffo Emma   Davis John   Fox Steven   Gloger Israel   Hosford David   Kinsey Emma   Jones Neil   Nock Christina   Roses Allen   Saunders Ann   Mark Skehel J.   Smith Marjorie   Cutler Paul  

Biomarkers, Vol. 13, Iss. 6, 2008-09 ,pp. : 618-636

Informa Healthcare

Access to resources Recommend Favorite